Jason Throne - 24 Feb 2023 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Legal Officer
Signature
/s/ Jason Throne
Issuer symbol
IDYA
Transactions as of
24 Feb 2023
Transactions value $
$0
Form type
4
Filing time
28 Feb 2023, 16:00:54 UTC
Previous filing
02 Mar 2022
Next filing
24 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +100K $0.00 100K 24 Feb 2023 Common Stock 100K $17.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.